Upcoming Events

Virtual Startup Demo Day

Tuesday, November 7, 2023 (11:00 AM - 1:00 PM) (EST)


Hosted in collaboration with RedCrow, please join us for this FREE virtual event featuring some of today’s hottest startups in medtech including the MassMEDIC 2023 IGNITE cohort! 

Register Now

The 2023 IGNITE Cohort includes:

  • Aim Medical Robotics is working to bring high levels of precision, automation, and efficiency to the complex environment of neurosurgery. Aim is developing a portable MRI compatible surgical robot for use in the MRI suite and the operating room.  

  • Brainbot has developed the first gamified concussion recovery app that facilitates rehabilitation through health optimization and self-management at home.  

  • Craniosense is changing the trajectory of care for TBI patients by enabling all healthcare providers to identify those at risk of intracranial hypertension, anytime, anywhere. 

  • Deeplook Medical partners with innovators in medical imaging with the latest in image display technology, innovative AI platforms and cloud-enabled image viewers. FDA-cleared DL Precise automates lesion segmentation and measurement with unprecedented precision in multiple imaging modalities (ultrasound, mammography, CT, MRI) – all with a single click.  

  • GuidewireRx has developed VascularAssistTM, an artificial intelligence platform for radiologists and hospitals to assist in the timely diagnosis of peripheral vascular disease to prevent amputation. 

  • NED Medical is seeking to transform oncology embolization therapy from a palliative to a curative-intent treatment with the mission of improving outcomes for patients with unresectable tumors. 

  • PMD Solutions is the maker of RespiraSenseRespiraSense transforms the measurement of a patient’s respiratory rate with continuous, innovative technology monitoring – improving the measurement and identification of deterioration, in real-time to help save lives. 

  • RhinUS is a medical device developed to treat the root cause of chronic rhinosinusitis (CRS), a condition affecting more than 30M Americans. Conceived by two engineers at Harvard Medical School, RhinUS combines the ease of in-office treatments with lasting symptom relief for CRS patients.   

RedCrow start-ups include:

Actuated Medical for SonoShield
For over 16 million Americans grappling with neurological conditions like stroke, Parkinson’s, and paralysis, a groundbreaking solution is on the horizon to lost restore function. Brain computer implants hold the promise of restoring lost function. But they have a major challenge because the human body treats these implants as foreign bodies which triggers a response that limits the implant’s working lifetime. Actuated Medical’s innovative SonoShield™ Defender uses precisely engineered sound waves to help minimize this foreign body response. Early testing is demonstrating the promise of SonoShield Defender to extend implant working lifetime.

Bio-Superior is developing therapeutics for the treatment of life-threatening respiratory disease based on a unique drug delivery platform. Our first drug candidate is for the treatment of lung inflammation in preterm infants, bronchopulmonary dysplasia. This is a serious unmet medical need that affects about 15,000 preterm infants and costs US Healthcare over $1B annually. Our drug delivery platform increases the spread of drug over tissue surfaces and promotes transport of the drug into the affected tissue. We expect that this technology will lead to valuable treatments for ARDS, COPD, adenocarcinoma, and other lung diseases. 

MARAbio is a precision-medicine company whose mission is to detect and treat the biological basis of Maternal Autoantibody Related Autism (MARA).

Tuesday, November 7, 2023 (11:00 AM - 1:00 PM) (EST)
Powered By GrowthZone